Showing results (81-90 of 335) with videos related to
Sort By:
Pageof 34
Cancer Chemotherapy and Pharmacology|March 13, 2015
Pharmacokinetically based dosing of weekly paclitaxel to reduce drug-related neurotoxicity based on a single sample strategyStefanie Kraff, Annemieke J M Nieuweboer, Ron H J Mathijssen, et al.European Journal of Cancer (Oxford, England : 1990)|October 9, 2012
The kinase RSK2 modulates the sensitivity of ovarian cancer cells to cisplatinMarijn T M van Jaarsveld, Iris C J Blijdorp, Antonius W M Boersma, et al.Cancer Treatment Reviews|December 3, 2023
Review - The impact of pharmacogenetics on the outcome of immune checkpoint inhibitorsKarlijn de Joode, Niels Heersche, Edwin A Basak, et al.Therapeutic Drug Monitoring|September 24, 2025
Therapeutic Drug Monitoring of Oral Targeted Anticancer Drugs: Achievements, Experiences, Challenges, and the Path ForwardMaud B A van der Kleij, Karolijn W M Groot Beumer, Stijn L W Koolen, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 26, 2024
Staging laparoscopy in gastric cancer patients: From a Dutch nationwide Delphi consensus towards a standardized protocolKaren van der Sluis, Niels A D Guchelaar, Lianne Triemstra, et al.The Lancet. Oncology|May 4, 2020
Clinical implications of food-drug interactions with small-molecule kinase inhibitorsG D Marijn Veerman, Koen G A M Hussaarts, Frank G A Jansman, et al.Plos Computational Biology|March 4, 2021
Physiologically based pharmacokinetic/pharmacodynamic model for the prediction of morphine brain disposition and analgesia in adults and childrenLaurens F M Verscheijden, Carlijn H C Litjens, Jan B Koenderink, et al.JCO Oncology Practice|February 21, 2025
Environmental Impact Assessment of Intravenous Versus Subcutaneous Monoclonal Antibodies: A Carbon Footprint AnalysisMichiel Zietse, Thirza Kooijman, Ruben Malmberg, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 3, 2023
Validation of an LC-MS/MS method for simultaneous quantification of abiraterone, enzalutamide and darolutamide in human plasmaStefan A J Buck, Peter de Bruijn, Inge M Ghobadi-Moghaddam-Helmantel, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2021
Precision Dosing of Targeted Therapies Is Ready for Prime TimeStefanie L Groenland, Remy B Verheijen, Markus Joerger, et al.Pageof 34